K-pop

C-Ya’s Nam Gyu-ri Releases New Solo Album, “Let’s Do That Kind of Love”

To be released on the 6th in the form of a digital album C-Ya Also Completes Their Nationwide Tour Schedule

KIM HYUNSIK
2026-09-04 15:08:43
[Edaily Starin KIM HYUNSIK Reporter] Singer and actress Nam Gyu-ri will release her digital album “Let’s Do That Kind of Love” (U.Sa.Geu) on the 6th, her agency Yuseung Company announced on the 4th.
(Photo: Nam Gyu-ri’s YouTube)
This album features two new songs perfect for fall. A single melody was arranged in different styles and divided into Part 1 and Part 2.
The agency explained, “Part 1 showcases her lovely and delicate vocals, while Part 2—featuring violinist KoN—showcases her soulful and powerful vocals.”
Nam Gyu-ri said, “I will continue to release new songs regularly to share music that reflects my growing maturity as an artist.”
Meanwhile, Nam Gyu-ri is also actively participating in activities with the group SeeYa, which reunited to mark the 20th anniversary of their debut. SeeYa broke their 15-year hiatus by releasing their full-length album *First, Again* last May. On the 29th and 30th of last month, they held the first performances of their national tour concert *THE FAN* at Kyung Hee University’s Peace Hall.
Siya’s national tour will continue in cities including Busan, Daegu, Goyang, Suwon, Cheongju, and Incheon.

Economy

Corporation

IT·Science

Economy

Shifting from Short-Term to Medium- and Long-Term... Appeal of Commercial Paper as a Funding Source Plummets

Fluctuations in credit spreads serve as an indicator of investor sentiment and capital flows in the corporate bond market. “Credit Signal” provides an intuitive analysis of the market’s overall trends…
2026-10-23 17:57:04

Corporation

Jeong Yong-jin Starts by Replacing E-MART Co., Ltd.’s CEO… Appoints Entire Executive Team in Their 40s

Shinsegae Co.,Ltd Chairman Chung Yong-jin is returning to the forefront of management at E-MART Co., Ltd.(139480). Unlike in 2013, when he stepped down as a registered director and entrusted the busin…
2026-10-23 14:55:06

IT·Science

HANALL BIOPHARMA CO.,LTD’s ‘Batoclimab’ Receives First New Drug Approval in China Nine Years After Technology Export

“Batoclimab,” a treatment for autoimmune diseases developed by HANALL BIOPHARMA CO.,LTD(009420), has received new drug approval in China. This comes approximately nine years after the company licensed…
2026-10-23 21:05:02